Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom Macroglobulinemia.
Tsakmaklis N, Hunter ZR, Liu X, Kofides A, Liu S, Guerrera ML, Guijosa A, Sun H, Hatcher JM, Peachey A, Patterson CJ, Meid KE, Gustine J, Branagan AR, Sarosiek S, Castillo JJ, Treon SP.
Tsakmaklis N, et al. Among authors: hunter zr.
Blood Adv. 2026 Jan 16:bloodadvances.2025018605. doi: 10.1182/bloodadvances.2025018605. Online ahead of print.
Blood Adv. 2026.
PMID: 41544209
No abstract available.